Synergistic Oral Pain Relief Systems
Legal Citation
Summary of the Inventive Concept
Integrating patented oral pain relief compositions with advanced technologies like AI, IoT, blockchain, and nanomaterials to create powerful, personalized, and connected systems for optimal oral pain management.
Background and Problem Solved
The original patent addressed oral pain relief through novel compositions, but it had limitations in terms of personalization, monitoring, and adaptability. The new inventive concept overcomes these limitations by incorporating distinct technologies to create a more comprehensive and effective solution.
Detailed Description of the Inventive Concept
The synergistic oral pain relief systems comprise a wearable device, an AI-powered pain assessment module, and a composition dispenser configured to dispense the patented oral pain relief composition. The AI-driven recommendation engine enables personalized treatment plans, while the IoT-enabled sensor monitors oral cavity conditions. The blockchain-based tracking system ensures secure and transparent pain level monitoring. The nanomaterial-based composition dispenser enhances the delivery of the pain relief composition.
Novelty and Inventive Step
The new claims introduce a novel integration of the patented oral pain relief composition with advanced technologies, resulting in a non-obvious and innovative solution that significantly improves oral pain management. The inventive step lies in the synergistic combination of these distinct technologies to create a more powerful and effective system.
Alternative Embodiments and Variations
Alternative embodiments may include variations in the wearable device design, AI-powered pain assessment algorithms, composition dispenser materials, and blockchain-based tracking systems. Additionally, the inventive concept could be adapted for use in other pain relief applications, such as topical or transdermal delivery.
Potential Commercial Applications and Market
The synergistic oral pain relief systems have significant commercial potential in the oral healthcare industry, particularly in the areas of dental care, orthodontics, and oral surgery. The target market includes dental professionals, oral healthcare companies, and consumers seeking advanced pain relief solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/006 |
| A | A61 | A61K31/045 |
| A | A61 | A61K31/047 |
| A | A61 | A61K31/085 |
| A | A61 | A61K36/53 |
| A | A61 | A61K36/534 |
| A | A61 | A61K36/9064 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/26 |
| A | A61 | A61P23/02 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions and medical device technologies, specifically oral pain management systems with expertise in drug formulation, medical device design, and digital health technologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmacy, biomedical engineering, or medical technology, possessing knowledge of pharmaceutical formulations, medical device integration, and emerging digital health technologies
Obviousness Rationale
A PHOSITA would recognize that integrating the source patent's oral pain relief composition with digital technologies represents a predictable application of known technological convergence strategies in medical treatment systems. The combination of a well-established pharmaceutical composition with emerging digital health technologies follows standard innovation pathways in personalized medical interventions. The technical elements introduced in the PTD represent incremental improvements that would be obvious to a skilled practitioner seeking to enhance oral pain management through technological augmentation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,676 |
|---|---|
| Title | Compositions for oral pain relief |
| Assignee(s) | ORCA PRODUCTS, LLC |